Document ID: chunk:federal_register_of_legislation:F2025C00036:reg:22:p2
Version: federal_register_of_legislation:F2025C00036
Segment Type: reg
Provision Reference: reg 22 (pt 2/2)
Character Range: 289442–290214

regard the person as an applicant for the licence and may deal with the notification referred to in paragraph (1)(b), (2)(b), (3)(b), (4)(d) or (4A)(a) or (b) as if it were an application for a licence.
 (7) In spite of subregulation (6), a person who is regarded as an applicant for a licence because of the operation of that subsection may continue to manufacture therapeutic goods under the original licence until the application is determined.
 (8) If, at any time, the Secretary becomes aware that he or she has not been informed in accordance with this regulation of an event referred to in paragraph (1)(b), (2)(b), (3)(b), (4)(d) or (4A)(a) or (b), the Secretary may cancel the licence to which the event relates.

Part 5—Examination, testing and analysis of goods